BioXcel Therapeutics, Inc.
BTAIQ
$0.05
$0.009.56%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.71M | -12.69M | -12.55M | -30.91M | -19.19M |
| Total Depreciation and Amortization | 18.00K | 58.00K | 74.00K | 75.00K | 75.00K |
| Total Amortization of Deferred Charges | 774.00K | 502.00K | 469.00K | 440.00K | 393.00K |
| Total Other Non-Cash Items | 4.16M | -1.03M | -7.04M | 13.21M | 3.74M |
| Change in Net Operating Assets | 3.66M | 1.35M | 4.83M | -1.60M | 2.41M |
| Cash from Operations | -6.10M | -11.81M | -14.21M | -18.79M | -12.58M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -304.00K | -8.11M | -- | -- | -- |
| Issuance of Common Stock | 3.11M | 8.50M | 5.76M | 38.23M | 140.00K |
| Repurchase of Common Stock | -24.00K | -- | 0.00 | -16.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -62.00K | -158.00K | -115.00K | -686.00K | -3.00K |
| Cash from Financing | 2.72M | 232.00K | 5.65M | 37.53M | 137.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.38M | -11.58M | -8.56M | 18.75M | -12.44M |